After a Monday full of one-on-one meetings and video recordings, Tuesday will see pharmaphorum editor-in-chief Jonah Comstock starting the day at Informa’s Biotech Summit, where he’ll report on ses
In the latest episode of the pharmaphorum podcast, editor in chief Jonah Comstock speaks with Jennifer Goldsack, CEO of the Digital Medicine Society (DiMe).
Zealand Pharma has suffered another setback in its bid to bring glucagon receptor agonist dasiglucagon for ultra-rare disease congenital hyperinsulinism (CHI) to the US market.